Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A classification based on tumor budding and immune score for patients with hepatocellular carcinoma.

Oncoimmunology - 1 Jan 2020

Wei Li, Delin Zhang, Kefei Yuan, Hong Wu, Jiwei Huang, Yange Zhang

Abstract excerpt

Background: The role of immune profiling and tumor budding in hepatocellular carcinoma (HCC) remains largely unknown. This study evaluated the association between tumor budding and lymphocytic infiltration in HCC. Meanwhile, HCC patients were stratified based on tumor budding grade and immune score. Patients and methods: A total of 423 HCC patients were divided into training (n = 212) and validation (n = 211)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Exome Sequencing
Share to Liver Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 32002283
DOI: 10.1080/2162402X.2019.1672495
PMCID: PMC6959452

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A classification based on tumor budding and immune score for patients with hepatocellular carcinoma.PMID 32002283Read ↗

Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancerSemantic proximity Read ↗

Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancerSemantic proximity Read ↗

Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived XenograftsSemantic proximity Read ↗

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictionsSemantic proximity Read ↗

Epithelial Plasticity and an Immune Suppressive Microenvironment Underpin Tumour Budding in Colorectal CancerSemantic proximity Read ↗

Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinomaSemantic proximity Read ↗

Assessing the applicability and interobserver variability of tumor budding and poorly differentiated clusters in colorectal cancerSemantic proximity Read ↗

Novel insights into HBV‐hepatocellular carcinoma at single‐cell sequencingSemantic proximity Read ↗

Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.Semantic proximity Read ↗

Single-cell and machine learning approaches uncover intrinsic immune-evasion genes in the prognosis of hepatocellular carcinomaSemantic proximity Read ↗

Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.Semantic proximity Read ↗

Dissecting Novel Tumor Antigens and Immune Subtypes Guided mRNA Vaccine Development for HBV Related-Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.